CORVUS PHARMACEUTICALS INC. - COMMON STOCK
9,1300
25-ноября-24 13:06:32
15 мин. задержка
Акции
+0,1800
+2,01%
Сегодняшний диапазон
8,9550 - 9,3529
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Corvus Pharmaceuticals Announces IND Acceptance for Phase 1/1b Clinical Trial of CPI-818 in China
16 авг 2021 17:00:00 Источник Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2021 Financial Results
02 авг 2021 16:05:01 Источник Nasdaq GlobeNewswire
-
15 июл 2021 16:05:00 Источник Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
25 май 2021 16:05:00 Источник Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Completes Sale of $10 Million Through Its ATM Program
05 май 2021 09:00:01 Источник Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2021 Financial Results
29 апр 2021 16:05:01 Источник Nasdaq GlobeNewswire
-
25 мар 2021 08:30:00 Источник Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Announces Participation in Upcoming Investor Conferences
05 мар 2021 08:30:00 Источник Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Announces Closing of Public Offering of Common Stock
17 фев 2021 16:10:00 Источник Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Announces Pricing of Public Offering of Common Stock
12 фев 2021 09:00:00 Источник Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Announces Proposed Public Offering of Common Stock
11 фев 2021 16:01:00 Источник Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Initiates Phase 3 Clinical Trial of CPI-006 for Patients with COVID-19
04 фев 2021 07:30:00 Источник Nasdaq GlobeNewswire